ClinicalTrials.gov
ClinicalTrials.gov Menu

Usability of the PreView PHP for Home Use in Intermediate AMD Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00776451
Recruitment Status : Completed
First Posted : October 21, 2008
Last Update Posted : June 3, 2009
Sponsor:
Information provided by:
Notal Vision Ltd

Brief Summary:
To demonstrate the ability of intermediate AMD subjects to follow the instructions for use and properly operate on their own the Preview PHP in home use environment, after going through training session.

Condition or disease
Age Related Macular Degeneration

Detailed Description:
The study purpose is to demonstrate that the target population can use the system after going through a supervised training session. The PreView PHP will be operated in the same manner in the simulated setting as it will be in future home use.

Study Type : Observational
Estimated Enrollment : 66 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Usability of the PreView PHP for Home Use in Intermediate Age Related Macular Degeneration Patients
Study Start Date : November 2008
Actual Primary Completion Date : February 2009
Actual Study Completion Date : March 2009

Resource links provided by the National Library of Medicine


Group/Cohort
1
Subjects diagnosed with Dry AMD



Primary Outcome Measures :
  1. The proportion of subjects who successfully completed the test by themselves, in a home simulated environment [ Time Frame: 2 clinic visits ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Dry AMD subjects
Criteria

Inclusion Criteria:

  • Capable and willing to sign a consent form and participate in the study Subjects diagnosed as intermediate AMD in at least one eye
  • Age ≥65 years
  • VA with habitual correction better than 20/60 in the study eye
  • Ability to speak, read and understand instructions in English or Hebrew
  • Qualified to use the device by health care professional

Exclusion Criteria:

  • Evidence of macular disease other than AMD or glaucoma in the study eye
  • Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy, CFP.
  • Any non-macular related ocular surgery or macular surgery performed within 3 months prior to study entry in the target eye
  • Participation in another study with the exclusion of AREDS study
  • Patients diagnosed with geographic atrophy (GA)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00776451


Locations
Israel
Belinson Medical Center
Petach Tikva, Israel
Sponsors and Collaborators
Notal Vision Ltd
Investigators
Principal Investigator: Neil Bressler, Prof. JHMC

Additional Information:
Responsible Party: Osnat Ehrman, Notal Vision
ClinicalTrials.gov Identifier: NCT00776451     History of Changes
Other Study ID Numbers: PHP-US-01
First Posted: October 21, 2008    Key Record Dates
Last Update Posted: June 3, 2009
Last Verified: June 2009

Keywords provided by Notal Vision Ltd:
AMD

Additional relevant MeSH terms:
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases